Pathogenesis of peri-tumoral edema in intracranial meningiomas

Moncef Berhouma1,2, Timothee Jacquesson3, Emmanuel Jouanneau3

  • 1Skull Base Surgery Unit, Department of Neurosurgery B, University Hospital of Lyon, Hospices Civils de Lyon, Lyon, France. berhouma.moncef@gmail.com.

Neurosurgical Review
|August 26, 2017
PubMed

Insights

Peri-tumoral edema in brain tumors (meningiomas) is common and impacts patient outcomes. Its exact cause is unknown, but likely involves multiple factors, guiding future treatment strategies.

Area of Science:

  • Neuro-oncology
  • Neoplasm Research
  • Edema Pathogenesis

Background:

  • Peri-tumoral edema frequently complicates intracranial meningiomas, affecting patient morbidity and mortality.
  • Despite the prevalence of edema, causative factors like age, gender, tumor volume, and location have not been definitively identified.
  • The underlying pathogenesis of peri-tumoral edema in meningiomas remains largely debated, even with advancements in imaging and molecular biology.

Purpose of the Study:

  • To review and synthesize the current understanding of factors implicated in the pathogenesis of peri-tumoral edema in meningiomas.
  • To explore various hypotheses regarding the molecular and cellular mechanisms driving edema formation.
  • To identify potential therapeutic targets for managing peri-tumoral edema in meningioma patients.

Main Methods:

  • Comprehensive literature review of studies investigating peri-tumoral edema in intracranial meningiomas.
  • Analysis of proposed etiological factors, including molecular signaling pathways and cellular mediators.
  • Synthesis of evidence on the roles of vascular endothelial growth factor, metalloproteinases, interleukins, and other potential contributors.

Main Results:

  • Numerous factors have been investigated for their role in meningioma edema, but none have been conclusively proven as sole causative agents.
  • Current hypotheses suggest a multifactorial pathogenesis, likely involving a complex interplay of various molecular and cellular factors.
  • Vascular endothelial growth factor, matrix metalloproteinases, and interleukins are among the frequently cited potential contributors.

Conclusions:

  • The pathogenesis of peri-tumoral edema in meningiomas is complex and likely multifactorial, involving a combination of investigated elements.
  • Understanding these contributing factors is crucial for developing effective therapeutic strategies.
  • Further research is warranted to elucidate the precise mechanisms and validate potential therapeutic targets for edema management.